期刊文献+

尿激酶受体在肺癌组织中的表达

The Expression of Urokinase-type Plasminogen Activator Receptor in Lu ng Cancer
下载PDF
导出
摘要 研究尿激酶受体 (uPAR)在肺癌组织和非肺癌组织中表达的差异 ,探讨uPAR与肺癌浸润转移的关系。方法 用免疫组织化学S -P法检测uPAR在 52例肺部组织标本中的表达。结果 肺癌组uPAR的阳性表达率为 88.89% ,非肺癌组uPAR的阳性表达率为 6.2 5% ,两组比较差异有高度统计学意义 (P <0 .0 0 0 1)。uPAR的表达与肺癌患者的病理类型、性别和年龄无关 (P >0 .0 5)。结论 肺癌组织中有uPAR的异常高表达 ,uPAR在肺癌的生长。 Objective To study the difference of the expression of urokinase_type plsminogen activator receptor (uPAR) between human lung carcinom a tissues and non_malignant tissues.Abstract:Objective To study the difference of the expression of urokinase_type plsminogen activator receptor (uPAR) between human lung carcinom a tissues and non_malignant tissues.Methods The expression of (uPAR ) in 52 pulmonary tissues obtained through thoracic operation and bronchos copy were examined by S_P immunohistochemical technique.Results T he positive rate of uPAR in the lung cancer cases was 88.89% and that in the non _malignant cases was 6.25%.The difference of the two groups was statistically si gnificant(P<0.0001),but the expression of uPAR in the lung cancer did not show a significant correlation with age,sex and histological classification(P >0.05).Conclusion There is expression of uPAR in the tumor t issue,and uPAR plays a important role in promoting tumor growth,invasion and met astasis.
作者 钱斌 胡筠珠
出处 《苏州大学学报(医学版)》 CAS 2003年第6期686-688,共3页 Suzhou University Journal of Medical Science
关键词 尿激酶受体 肺肿瘤 转移 免疫组织化学 Urokinase_type plasminogen activator receptor Lung Cancer Metastasis Immunohistochemistry
  • 相关文献

参考文献5

  • 1[1]Dano K,Romer J,Nielsen BS,et al. Cancer invasion and tissue remodeling-cooperation of protease systems and cell types[J].APMIS,1999,107(1):120~127.
  • 2[2]Liu G,Shuman MA,Cohen RL.Coexpression of urokinase,urokinase receptor and PAI-1 is necessary for optimum,invasiveness of cultured lung cancer cells[J].Int J Cancer,1995,60:501~506.
  • 3[3]Mohanam S,Go Y,Sawaya R,et al. Elevated levels of urokinase-type plasminogen activator and its receptor during tumor growth in vivo[J].Int J Oncol,1999,14(1):169~174.
  • 4[4]Suzuki S,Hayashi Y,Wang Y,et al.Urokinase type plasminogen activator receptor expression in colorectal neoplasms[J].Gut,1998,43(6):798~805.
  • 5[5]Salden M,Splinter TA,Peters HA,et al. The urokinase-type plasminogen activator system in resected non-small-cell lung cancer[J].Ann Oncol,2000,11(3):327~332.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部